Biosafety Preclinical Trials of Xenogenic, Allogeniec and Autologous Progenitor Cells from Fat Tissue

V. S. Melikhova; I. N. Saburina; A. A. Orlov; V. D. Repin; N. I. Novikova; A. N. Murashev

Genes & Cells ›› 2008, Vol. 3 ›› Issue (3) :43 -46.

Original Study Articles

research-article

Biosafety Preclinical Trials of Xenogenic, Allogeniec and Autologous Progenitor Cells from Fat Tissue

Author information +

History +

Abstract

Due to wide spread of new methods of regenerative medicine on basis of stem cells it has become increasingly necessary to establish standards of techniques using them. Preclinical trial of a new technology after receiving preliminary experiment results is a primary stage of its adoption. We carried out the experiments to assess biosafety of autogenous, allergenic and xenogeneic cultures of human and rat cells in models under standard preclinical experiments conditions used in a presentday pharmacological practice.

Keywords

stem cells / preclinical trials

Cite this article

Download citation ▾

V. S. Melikhova, I. N. Saburina, A. A. Orlov, V. D. Repin, N. I. Novikova, A. N. Murashev. Biosafety Preclinical Trials of Xenogenic, Allogeniec and Autologous Progenitor Cells from Fat Tissue. Genes & Cells, 2008, 3(3): 43-46 DOI:

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. 2005; М., Медицина: 832.

[2]	Федеральный Закон «О лекарственных средствах». Принят Государственной Думой 5 июня 1998 г.

[3]	Astori G., Vignati F., Bardelli S. et al. «In vitro» and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J. Transl. Med. 2007; 5: 55.

[4]	Zuk P.A., Zhu M., Ashjian P. et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 2002; 13(12): 4279-95.

[5]	Bernardo M.E., Zaffaroni N., Novara F. et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007; 67(19): 9142-9.